Cameron
Dementia research ‘achingly slow’
June 20, 2014Research and Development, Sales and Marketing Alzheimer's, Cameron, Parkinson's, Parkinsons, UK, billings, dementia, research
The UK prime minister’s envoy on dementia has described progress on research into the neurodegenerative condition as ‘achingly slow’. Global …
Poll: UK opposed to Pfizer takeover bid of AZ
May 13, 2014Research and Development, Sales and Marketing AstraZeneca, Cameron, Pfizer, UK, buyout, merger, research
The UK’s largest union says a new poll shows that the vast majority of the British public are against Pfizer’s …
Pfizer appeals to UK prime minister
May 6, 2014Manufacturing and Production, Sales and Marketing AstraZeneca, Cameron, Pfizer, merger, research
Pfizer has attempted to enlist the help of UK prime minister David Cameron in its campaign to buy AstraZeneca, offering …
Pfizer/AZ deal would put UK research in jeopardy
May 1, 2014Research and Development, Sales and Marketing AstraZeneca, Cameron, Pfizer, UK, deal, merger, research
The UK’s medical research collective has come together to warn the government that any deal between US giant Pfizer and …
Biologics lift for UK
April 22, 2014Manufacturing and Production, Sales and Marketing Cameron, UK, biologics, darlington, nbmc
Work has begun on a key new £38 million centre in Central Park, Darlington, which should increase the biologics capability …
China ban for corrupt pharma firms
January 2, 2014Medical Communications, Sales and Marketing Cameron, China, GSK, Witty, bribery, lilly
UK government doubles dementia funding
December 11, 2013Research and Development, Sales and Marketing Alzheimer's, Cameron, Merck, Obama, dementia
UK prime minister David Cameron has announced that the government is to increase funding research into dementia, spending £52 million …
GSK using ‘sledgehammer’ tactics on agencies
November 29, 2013Sales and Marketing Cameron, China, GSK, horlicks, sky
GlaxoSmithKline is being accused of using ‘sledgehammer’ tactics by marketing agencies promoting its products after the firm allegedly demanded cash …
Hunt: ‘We will never cover up’
October 2, 2013Sales and Marketing CQC, Cameron, Hunt, NHS
In a speech which mixed the personal and the political at the Conservative Party conference in Manchester yesterday, health secretary …
Cancer Drugs Fund to run until 2016
September 30, 2013Research and Development, Sales and Marketing CDF, Cameron, NHS, NICE, VBP
England’s Cancer Drugs Fund will run until 2016 and be given a £400 million boost under plans announced by the …
Cancer Drugs Fund to stay, government to announce
September 27, 2013Medical Communications, Sales and Marketing CDF, Cameron, NHS, NICE, VBP, prime minister
The UK’s prime minister is set to announce that the controversial Cancer Drugs Fund will remain in place after March …
Report: ‘Improve NHS safety’
August 7, 2013Sales and Marketing Cameron, Hunt, Mid Staffs, NHS
Patient safety is the key to future NHS success, according to a new review commissioned after the final report of …
Targeted radiotherapy from 2018
August 2, 2013Sales and Marketing Cameron, NHS, proton beam
Proton beam therapy, a targeted form of radiotherapy, is to be available at hospitals in Manchester and London from 2018 …
UK government launches ‘Genomics England’
July 8, 2013Research and Development, Sales and Marketing Cameron, DH, Genomics england, Hunt, NHS
The government has invested £100 million into a new DNA mapping service for patients, and will begin with cancer, rare …
Pfizer targets Newcastle
May 15, 2013Research and Development, Sales and Marketing ABPI, Cameron, NHS, Newcastle, Pfizer
Pfizer has earmarked Newcastle Hospitals NHS Foundation Trust as one of 60 sites worldwide to take part in a key …
Latest content
One in three UK women with migraine say symptoms taken less seriously
Report highlights scope to expand day surgery
Sygnature formalises drug discovery collaboration with X-Chem
Codis appoints Steven Facer as chief commercial officer
Danish medical cannabis use rises as regulator reports no new safety signals
